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Abstract
Several important nematode parasites have been found to express members of a gene family variously termed as venom allergen
antigen homologue (ah) or Ancylostoma secreted protein (asp). In some cases these products are secreted by infective larval stages
and have been suggested to be effective vaccine immunogens. We isolated the corresponding gene from the human filarial
nematode, Brugia malayi, by first searching the expressed sequence tag (EST) dataset generated by the Filarial Genome Project
and then using gene-specific nondegenerate primers matching the selected gene for CR, from B. malayi cDNA libraries. We
report here the full-length gene sequence, which we have designated as Bm-al-1, for ah/asp-like. The corresponding protein
(Bm-VAL-1) contains 232 amino acids in a single homology unit, unlike products from some other species in which there is a
tandem repeat. A putative signal sequence is present at the 5 end and there are two potential N-glycosylation sites. Murine
antibodies to recombinant Bm-VAL-1 react with a 28 kDa protein in L3 extracts and recombinant Bm-VAL-1 is recognised by
murine T cells primed with soluble L3 proteins. Of 82 ESTs corresponding to Bm-al-1, 72 are recorded from the infective larval
(L3) stage. However, PCR on the first-strand cDNA libraries from later mammalian stages revealed some expression at most
subsequent time points. Over 95% (20/21) of microfilaraemic human filariasis patients are seropositive for antibodies to
Bm-VAL-1, with particularly high levels of IgG3 and IgG4 isotypes. The IgG4 subclass may indicate stimulation by adult and/or
microfilarial-derived immunogens. The association of Bm-VAL-1 with the infective stage and its recognition by humans exposed
to filariasis suggests that further evaluation of this antigen as a vaccine candidate should be performed. © 2001 Published by
Elsevier Science B.V.
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1. Introduction
The infective third-stage larvae of many parasitic
nematodes undergo the most critical transition of the
life cycle, from a free-living or arthropod-borne exis-
tence to the definitive, often mammalian, host [1,2].
Products from these stages are of particular interest as
key mediators of the invasion process and as potential
immunogens for anti-parasite vaccines [3–5]. When
similar proteins are associated with larval stages of
many different nematode species, a common pathway
or essential component of the infection process may be
inferred. One such instance is the group of proteins first
described as Ancylostoma caninum secreted protein or
ASP [6] with similarity to a wider family including, for
example, hymenopteran venom allergens. Significantly,
these products are released when resting larvae are
stimulated to commence invasion. The venom allergen
antigen homologue VAH/ASP family contains two dis-
 Note: Nucleotide sequence data reported in this paper have been
submitted to the GenBank™ data base with accession number
AF334661.
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tinct forms, typified in A. caninum [7]: Ac-ASP-1 is a
long-form 42 kDa protein while Ac-ASP-2 is a short-
form 20–22 kDa product. Sequence analysis reveals
that Ac-ASP-1 contains a tandem nonidentical repeat
of an ancestral unit represented only once in Ac-ASP-2
[7].
Members of this gene family have now been reported
from a range of nematode species. In the sheep intesti-
nal nematode Haemonchus contortus, both the large-
form Hc40 [8] and short-form Hc24 [9,10] have been
identified. Multiple homologues have been discovered
in the two human hookworm species Ancylostoma duo-
denale and Necator americanus [11,12], and also in
Meloidogyne incognita [13], Onchocerca olulus [14]
and Toxocara canis [15]. Additional gene members in
Ascaris and Strongyloides have also been indicated by
hybridisation experiments with Ac-asp-2 probes [7].
Further, a homologue from the filarial nematode
Dirofilaria immitis was selected by reactivity with im-
mune dog serum (Tripp C, Wisnewski N, unpublished
deposition) and a related gene in Brugia malayi re-
ported from expressed sequence tag (EST) analysis [4].
Significantly, up to 17 homologous genes have been
identified in the genome of Caenorhabditis elegans
[7,12]. All but one of these are single-unit forms (e.g. C.
elegans C39E9.1), the exception being F11C7.3 which
displays a paired but nonidentical repeat structure [8].
More distant relatives of the VAH/ASP family can
be found across a wide evolutionary spectrum. Within
A. caninum, a related gene encodes a neutrophil in-
hibitory factor (NIF), which displays an antagonistic
binding to the integrin receptor M2 (CD11b/CD18,
Mac-1) on mammalian cells [16]. While the aforemen-
tioned insect venom allergens have no known function,
they are similar to helothermine, a lizard salivary toxin,
which blocks the ryanodine receptor [17]. In mammals,
similar proteins have been described as the testis-spe-
cific proteins TPX-1, sperm-coating glycoprotein (SCG)
and cysteine-rich secretory protein (CRISP) [18], as well
as P25TI, a novel trypsin inhibitory protein upregulated
in some tumour lines [19]. The larger gene family also
includes an interesting set of plant defence proteins, all
characterised by a conserved signature of key residues
[7]. From these similarities, it is difficult to deduce a
general function for nematode homologues, but it is
attractive to postulate inhibition or activation of host
receptor-dependent processes. For example, the O-
ASP-1 and O-ASP-2 proteins from Onchocerca
olulus have been shown to promote corneal angiogen-
esis when injected into mice [14], a role in keeping with
the formation of vascularised nodules in onchocerciasis.
Because vaccines against nematode parasites focus on
the infective larval stage, heightened expression of ah/
asp genes in larvae make these products an attractive
candidate vaccine antigen [20]. Promising results have
so far been obtained in two different species. Thus, four
out of five sheep vaccinated with a fraction enriched
with H. contortus Hc-24 were protected against estab-
lishment of adult parasites [21], while ASP-1-immunised
mice show up to 80% reduction in infection [22,23].
The Filarial Genome Project has provided a major
resource and impetus for gene discovery from B. malayi
and other filarial nematodes [4,24–28]. EST sequences
deposited for B. malayi include a number correspond-
ing to a homologue of ASP [4,25,28]. We describe here
the characterisation of this homologue, and its expres-
sion as a recombinant probe for immunological reactiv-
ity of patients infected with this major human tropical
pathogen.
2. Materials and methods
2.1. Database searching
The ungapped TBLASTN algorithm was used with
the A. caninum ASP-1 protein sequence matched
against all deposits in the NCBI dbEST nucleotide
database translated into all six frames [29]. Multiple
ESTs with significant similarity were found, permitting
a putative full-length sequence to be assembled. From
this, a 5 gene-specific primer was designed to amplify
the gene by PCR from an L3 cDNA library, 5-AGT
ACT TAC TAG ACG ACA TCT TAC TGT T-3
(roman typeface nt −68 to −54, 5 of the start
codon), in conjunction with M13 reverse primer for a 3
vector sequence. This product was cloned and se-
quenced in full.
2.2. PCR amplifications and 5  RACE
The 5 end of the Bm-al-1 cDNA was amplified
using the rapid amplification of cDNA ends (RACE)
procedure following the supplier’s instructions (Gibco-
BRL). Starting with mixed adult B. malayi total RNA,
first-strand cDNA was synthesised from a primer se-
quence close to the 5 end of the cDNA clone; this
primer was 5-TAG TCG ACC TCC TGG ACA TTC-
3 (complementary to nt 72–52 of cDNA in which the
initiating ATG codon is numbered 1–3). PCR was then
performed with an anchor primer supplied in the kit
and a second gene specific primer: 5-AAC GAA AAA
TAA CAT TTT GCC GAG-3 (complementary to nt
15 to −9). The PCR products were ligated into the
pMOS-blue vector. Clones were picked at random and
fully sequenced.
2.3. Reerse transcription-PCR
First-strand cDNA was produced from total RNA
using GeneAmp RT-PCR kits (Applied Biosystems,
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al-1- specific primers were used on first-strand cDNA
for 30 cycles of 1 min at 99 °C, 1 min at 55 °C and 1.5
min at 72 °C. The primers used were ATT TGA ATG
TCC AGG AGG TCG A, corresponding to nt 49–69,
and TTT TTC TAC ACA ATC CAG ATT T, corre-
sponding to nt 660–640; in each case an additional
nucleotide (italicised) was added at the 5 end.
2.4. Expression and antibody analysis
Recombinant Bm-VAL-1 protein was expressed in E.
coli by cloning the presumed mature coding sequence (a
609 bp insert encoding aa 17–220) into the pET-29T
vector (Novagen), following PCR with the two primers
described above (49–69 and 660–640). Protein expres-
sion was induced in BL21(DE3) cells with 1 mM IPTG
for 3 h at 37 °C. Bacteria were pelleted and sonicated
in a 6 M urea buffer suitable for metal chelating
chromatography on His-bind resin (Novagen). Eluted
protein was dialysed against PBS, and recovered at a
final concentration of 2 mg ml−1. Both BALB/c and
CBA/Ca mouse strains were immunised with two doses
of 10 g rBm-VAL-1 (first in complete Freund’s adju-
vant, the second in incomplete), one month apart.
Serum samples taken 7 and 14 days following the boost
showed that only the BALB/c responded with a poly-
clonal antibody response. For Western blots, whole
microfilarial (Mf), L3 and adult worms were solublised
directly in PBS, or 1.5% n-octylglucoside (nOG,
Sigma), or in SDS-PAGE loading buffer. Samples were
subjected to SDS-PAGE and electrotransfer, then
probed with a 1/200 dilution of murine anti-Bm-VAL-1
or normal mouse serum, followed by peroxidase anti-
mouse Ig (BioRad, 1/2000) and ECL substrate.
2.5. Murine T cell reactiity
BALB/c mice were immunised with 10 g of soluble
extract of L3 mixed with an equal volume of complete
Freund’s adjuvant (Sigma) in the rear footpad. Ten
days later, popliteal lymph node cells were recovered
and cultured as described in detail elsewhere [30]. The
data were compared by the two-tailed t-test and a P
value of 0.05 or less was considered significant.
2.6. ELISA
Sera from 42 adult individuals residing in the Palu
Valley area of Central Sulawesi, Indonesia, which is
endemic for B. malayi filariasis, were tested for isotype
specific antibodies to recombinant Bm-VAL-1. Of these
patients, 21 were patent microfilaraemic (range 40–
3300 Mf ml−1) and 21 asymptomatic amicrofilaraemic
(exposed but ‘endemic normal’) individuals. Recombi-
nant antigen was coated onto Nunc immunoplates at 1
g ml−1 in 0.06 M carbonate buffer and plates were
otherwise treated as described previously for analyses
of responses to whole B. malayi antigens [31,32].
3. Results and discussion
3.1. Search of dbEST for ASP homologues
The A. caninum ASP-1 sequence was used to screen
the NCBI dbEST database containing the Filarial
Genome Project EST sequences from multiple stages of
B. malayi. Of approximately 18 700 sequences, 82
showed high levels of similarity and 72 of these were
from the infective L3 stage larval cDNA library. This
represents an abundance of 2.22% (72/3249 L3 ESTs).
Similar levels of abundance have been observed for the
related nematode O. olulus [14]. Three more cDNAs
were noted from the Mf stage, five from post-infection
larvae and two from adult male worms [28]. Closer
inspection of these sequences indicated that all were
derived from the same gene, which has been assigned a
single cluster number (BMC00351) by the Filarial
Genome Project.
3.2. PCR amplification and 5  RACE
The longest EST contained an open reading frame of
220 amino acids, equivalent to a single homology unit
of Ac-ASP-1. As Ac-ASP-1 and H. contortus Hc40
were known to contain tandemly duplicated domains,
the possibility that Bm-al-1 encodes a larger protein
was investigated. From first-strand cDNA of mixed
adult-stage parasites, a primer close to the known 5
end was used for 5 RACE. However, no longer
product was obtained in the two experiments, although
the same protocol and reagents were successful for
other transcripts [33]. No product was obtained in
amplifications with the nematode 22-nt spliced leader
and a Bm-al-1 specific primer, although parallel condi-
tions amplified a number of other larval cDNAs [2]. All
ESTs for which appropriate sequence had been
recorded encoded a stop codon at nt 661–663 indicat-
ing that no second 3 domain exists.
3.3. Sequence of B. malayi espid (enom
allergen)/Ancylostoma (secreted protein)-like product
(Bm-VAL-1)
The open reading frame encodes 220 amino acids, of
which the first 16 represent a putative signal sequence.
The presence of this hydrophobic motif further indi-
cates that the sequence represented here is the authentic
full-length product. This sequence differs at two nucle-
otide positions from that deposited by McCarthy and
Hopkins (AF042088). These substitutions are each syn-
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which data are available, 11 (65%) have the two nucle-
otides reported by McCarthy and six (35%) have the
two we describe here. Such differences may well repre-
sent allelic forms among the B. malayi gene pool, as
noted at other loci [34]. This indication of sequence
polymorphisms is not surprising in the light of Qiang et
al.’s recent report of no less than 42 nucleotide varia-
tions (of which 12 were nonsynonymous) among Ac-
asp-1 genes from different A. caninum isolates [35].
Other features of the protein sequence include two
N-glycosylation sites and a preponderance of cysteine
residues in the C-terminal segment (aa 164–220), which
contains seven of the ten cysteines in the protein.
3.4. Eolutionary relationship of VAH/ASP-like (VAL)
family members
The nematode VAL proteins show characteristics of
a larger protein family, designated pfam00188 and also
known as SCP (sperm coating protein)-like with homo-
logues of mammalian, insect, fungal and plant origins.
The same family has also been named CAP, to denote
Cysteine-rich secretory proteins of mammals, vespid
venom Allergens, and plant Pathogenesis-related
proteins [36]. Bm-VAL-1 shares 17 of the 19 residues
identified as conserved across the whole CAP family
(Fig. 1).
Cladograms summarising the likely phylogeny of
these genes have recently been published in which all
the filarial VAL sequences form a monophyletic group
distinct from other nematode genes, with 97–100%
bootstrap support [12,14]. Within the filarial ne-
matodes, Bm-VAL-1 is most similar to Wb-VAH-1,
sharing 91% amino acid identity (Fig. 1). Other filarial
VAL sequences in the public databases include one
from the dog heartworm (D. immitis) and three homo-
logues from O. olulus, of which only O-ASP-3 is
expressed by the L3 stage [14]. ESTs for a VAL homo-
logue are also available for Litomosoides sigmodontis
[37]. The complete filarial sequences, together with the
canonical A. caninum ASP and a representative venom
allergen from the hymenopteran fire ant, are also com-
pared in Fig. 1.
3.5. Expression by different life cycle stages
The pattern of expression of Bm-al-1 can be fol-
lowed through the mammalian life cycle of B. malayi by
RT-PCR from first-strand cDNAs taken at 1- to 2-day
intervals over the first 4 weeks’ infection of jirds from
L3 to the adult stage. The mRNA is strongly repre-
sented in the mosquito-borne L3 stage, as well as at
certain other life cycle points such as maturing L4 and
young adult worms (Fig. 2). Moreover, expression oc-
curs in the Mf stage as reflected in ESTs derived from
Fig. 1. Alignment of filarial VAL proteins with homologues from Ancylostoma and the fire ant. Authors’ designations of genes as VAH or ASP
have been respected. Alignments were prepared using the ClustalW facility on MacVector 7.0. All cysteine residues are displayed in black. Lollipop
symbols identify the two potential N-glycosylation sites, both of which are shared with Wb-VAH-1, and one of which is present in Di-VAL-1.
Inverted triangles denote codons found to show synonymous nucleotide polymorphisms (nt 217/219, AAC/AAT, both Asn; and nt 349/351
ACC/ACG, both Thr). Residues identified as characteristic of the CAP family from mammals, insects, nematodes and plants [35] are circled above
the alignment, heavier shading denoting conservation within the nematode sequences shown. Accession numbers of the sequences presented are
as follows: W. bancrofti VAH-1, AF109794; Dirofilaria immitis VAL, AF001100; O. olulus ASP-1, AF020586; A. caninum ASP-1, AF132291;
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Fig. 2. Expression of Bm-al-1 during the mammalian stages of the B. malayi life cycle. The stage and timing of the moults following infection
of the mammalian host are indicated above the panel showing PCR products amplified from each time point. d0 represents mosquito-derived L3.
mRNA taken at each time point was used to make first-strand cDNA as templates in PCR reactions using the Bm-al-1-specific primer pair
detailed in Section 2. As a control, primers for Bm-lid-1 (a homologue of Ov-L3 from O. olulus, Murray J, Maizels RM, unpublished) show
constant expression from all stages tested.
the Mf library. Thus, transcription does not show com-
plete developmental restriction.
3.6. Natie Bm-VAL-1 is a 28 kDa L3 protein
Expression of the Bm-VAL-1 protein was also moni-
tored using a polyclonal antibody raised to the recom-
binant protein. Western blot analysis with PBS-soluble
extracts of the three major life cycle stages (Mf, L3 and
adults) reveals antibody-reactive proteins in both Mf
and L3 (Fig. 3A). The L3 component has an estimated
molecular weight (mol. wt.) of 28 kDa. A strong Mf
band can also be seen with a slightly faster mobility,
but no corresponding antigen is present in adult ex-
tracts. Interestingly, some fainter bands are apparent in
the higher mol. wt. ranges. Since many nematode spe-
cies are known to encode multiple VAL-type genes (e.g.
two in Haemonchus, 9 in Necator, 17 in C. elegans),
it is possible that these weaker reactions represent
related but distinct VAL gene products.
While Bm-VAL-1 protein is present in PBS-soluble
extracts, some of the product requires detergent for its
release (Fig. 3B). Moreover, the harsher conditions of
SDS-2ME solubilise a reactive form of approximately
40 kDa. Again, comparison with other species suggests
that this may represent a different member of the same
gene family in B. malayi.
Several experiments were undertaken to establish if
Bm-VAL-1 is secreted by infective larvae. Overnight
incubation of mosquito-derived L3 in a variety of con-
ditions (1000 L3 ml−1 of RPMI or Grace’s medium at
26 or 37 °C) did not result in the release of sufficient
Bm-VAL-1 protein to be detected by Western blot,
although another highly-expressed larval protein (Bm-
ALT-1) could readily be observed under these condi-
tions. If Brugia larvae, like Ancylostoma larvae, require
a developmental cue to stimulate release of the ASP-
like VAL protein, it could be argued that only exposure
to mammalian factors in vivo can provide the necessary
signal. Thus, the question of whether Bm-VAL-1 func-
tions as an exo-antigen within the host environment
remains to be resolved.
3.7. Expression and reactiity of Bm-VAL-1
A panel of human filariasis sera was tested for anti-
body recognition of recombinant Bm-VAL-1-protein
and high levels of serological reactivity were observed
(Fig. 4). Two groups of individuals were studied:
asymptomatic amicrofilaraemic persons, who are clini-
cally normal but exposed and may harbour cryptic
infections (Mf− ); and microfilaraemic patients with
circulating parasites (Mf+ ). In the first subset of en-
demic normals, 18/21 (86%) were seropositive in at least
one of the 4 IgG subclasses of antibodies to Bm-VAL-
1, while in Mf+ patients, the proportion was 20/21
(95%). The most vigorous antibody isotypes observed
were IgG3 and IgG4.
The IgG3 isotype has previously been linked to pro-
tective immunity to the L3 stage [38–40], while the
presence of IgG4 is strongly associated with exposure
to adult worms and microfilariae [41]. Because previous
work suggests that larval antigens do not elicit IgG4
responses [32], the presence of anti-Bm-VAL-1 IgG4
may reflect a low level of expression by adult and
microfilarial stages.
3.8. Immunogenicity to T cell populations
To test whether T cell responses were likely to be
mounted to VAL, mice were immunised with soluble
proteins from the infective larval stage. When primed
lymph node cells were challenged in vitro with rBm-
VAL-1, a significant proliferative response was ob-
served in every experiment (Fig. 5; P0.005). Assays
for antigen-specific cytokine release showed that levels
of IL-4 and IFN- produced in response to Bm-VAL-1
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control) values (data not shown). Human T cell re-
sponses were also gauged by stimulation of PBMC
from filariasis patients. Positive proliferative responses
were observed in some patients, but in only one case
was significant production of IFN- noted (Sartono E,
Yazdanbakhsh M, personal communication).
Fig. 4. Specific antibody responses in human filariasis patients. Anti-
body levels specific for Bm-VAL-1 in the sera of 21 Mf-negative
endemic normal subjects () and 21 microfilaraemic patients ()
were measured by ELISA for IgG1, IgG2, IgG3 and IgG4 using
plates coated with 1 g ml−1 recombinant antigen. All patients were
adults residing in an area of Central Sulawesi, Indonesia, endemic for
B. malayi. The cut-off values are represented by the shaded boxes and
are derived from the mean of three European normal control values
plus three SD.
Fig. 3. Western Blot identification of native Bm-VAL-1 antigens. (A)
Mf (track 1) and L3 (track 2) 10 g of PBS-soluble extracts were
probed with polyclonal mouse antibody to recombinant Bm-VAL-1
(left panel). No reaction was observed with adult extracts (track 3) or
with normal mouse serum (NMS, right panel). (B) L3 extracted
sequentially with PBS (track 1), nOG (track 2) and SDS-PAGE
loading buffer (track 3) were probed with mouse antibody to rBm-
VAL-1 (left panel). No reaction was observed with NMS (right
panel).
Fig. 5. T cells from L3-immunised mice respond to Bm-VAL-1.
BALB/c mice were immunised with 10 g of soluble L3 extract
proteins in complete Freund’s adjuvant subcutaneously in the foot-
pad. Ten days later, popliteal lymph node cells were taken and
cultured in vitro in the presence of 10 g ml−1 recombinant VAL
protein. Positive controls included Bm-ALT-1 (an abundant L3
protein [5]), mycobacterial PPD (a constituent of complete Freund’s
adjuvant) and the L3 extract used for initial immunisation. Data
represent the means and standard deviations from groups of five
mice. The response to Bm-VAL-1 was significantly above media-
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3.9. Vaccination
Because of the prominence of Bm-al-1 among larval
cDNA transcripts and the success of similar products in
vaccination against other nematode species, recombi-
nant Bm-VAL-1 was used to immunise jirds. Following
four injections (the first of 75 g in complete Freund’s
adjuvant, two boosts of 25 g in incomplete Freund’s
adjuvant and a final boost of 7.5 g in IFA), jirds were
challenged with 300 mosquito-derived infective larvae
intraperitoneally. Four weeks later, the Bm-VAL-1-im-
munised group showed a mean reduction of 64% in
parasite recovery from the peritoneal cavity (immu-
nised: geometric mean 18.6, range 7–108; control given
adjuvant alone: geometric mean 50.9, range 13–195).
Although a substantial difference, this failed to reach
statistical significance (Mann–Whitney nonparametric
test, group sizes=6). A similar experiment was then
conducted, but again, no significant effect was observed
and only minimal reductions in recovery obtained. Fu-
ture work may aim to refine the immunisation protocol
and to combine Bm-VAL-1 with other candidate im-
munogens in a multivalent vaccine.
Vaccination against filarial nematodes offers a robust
strategy for eradication of this major tropical scourge
[42–44]. Recently, the recombinant B. malayi larval-
specific antigen Bm-ALT-1 was reported to elicit pro-
tective responses in jirds [5]. The expression of
Bm-VAL-1 is less stringently restricted to the L3 than is
the case for Bm-ALT-1 and the possibility remains that
VAL immunisation could prime pathogenic responses
against mature stages. Future vaccination studies will
need also to assess whether vigorous immune responses
to nematode VAL proteins carry any risk of harmful
reactivities either to environmental antigens (such as
may be encountered from insect bites), or to the en-
dogenous proteins in mammalian hosts such as the
testis-specific autoantigen Tpx [45].
4. Conclusions
The VAL family has become one of the most inten-
sively studied sets of genes from nematode parasites,
showing strong association with larval invasion of the
mammalian host. We report here that these products
do not go unnoticed by the host immune system and
suggest that an appropriate response to these antigens
may prove to be protective. It will now be important to
establish the biological function of the VAL proteins in
the host–parasite interaction, so that we can begin to
appreciate a fuller picture of how VAL products may
promote parasite infection and how immune responses
to these antigens may frustrate parasite survival.
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